People whose jobs require more complex work with other people, such as social workers and lawyers, or with data, like architects or graphic designers, may end up having longer-lasting memory and thinking abilities compared to people who do less complex work.
More than 40% of calls placed to US poison control centers concerning energy drinks involve children under age 6, some of whom suffer serious cardiac and neurological symptoms.
The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
Medication nonadherence is often disastrous for bipolar patients, as it can lead to poor impulse control, increased risk of hospitalization, and even suicide.
A dendritic cell vaccine for MS attacks the condition early, while preserving the immune system.
The FDA is permitting marketing of a replaceable urinary prosthesis for female adults with impaired detrusor contractility.
Neuroprotective nutrients appear to enhance cognition, memory, and other impaired functions seen in patients with Alzheimer's disease.
In response to the recent article by Gary M. Franklin, MD, MPH, titled "Opioids for chronic non-cancer pain: A position paper of the American Academy of Neurology," we wish to address a number of issues.
Sleep disorders may require independent diagnosis and management, researchers say.
A metaanalysis shows that levels of an antioxidative endogenous metabolic byproduct-uric acid-are correlated with disease activity in multiple sclerosis.
Adding panobinostat to a combination treatment of bortezomib and dexamethasone in heavily pretreated patients boosts progression-free survival, but overall survival data are not yet mature.
The results of an FDA safety review of omalizumab (Xolair) suggest the asthma drug slightly elevates the risk of serious cardiovascular and cerebrovascular adverse events.
Clinical pharmacists can reduce anti-epileptic drug (AED) prescription errors that commonly result from incomplete or poor documentation.
Disease modifying therapy maintains effects of interferon in the body for a longer duration.
In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.
Postmenopausal women who consume adequate amounts of potassium have reduced stroke risk.
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome.
Genzyme's alemtuzumab (Lemtrada) and Biogen's dimethyl fumarate (Tecfidera) showed sustained efficacy in a broad range of MS patients.
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome.
Increased salt intake may magnify the risk of relapses in patients with multiple sclerosis.
Scientists discover how to stop cells from attacking healthy tissue.
Multiple sclerosis patients who used a balance board accessory for a video game console saw changes in brain connections and improved their balance.
Phase I study deems treatment safe and tolerable in humans.
Phase I study deems treatment safe and tolerable in humans.
